Vycor Medical (VYCO) Non-Current Assets (2010 - 2026)
Vycor Medical (VYCO) reported Non-Current Assets of $203024.0 for Q1 2026, down 40.31% year-over-year from $340136.0 in Q1 2025, and down 23.96% quarter-over-quarter from $266998.0 in Q4 2025.
Vycor Medical (VYCO) Non-Current Assets (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Non-Current Assets data on file, last reported at $203024.0 in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $203024.0, down 40.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (down 23.52% YoY), and the FY2025 annual result was $266998.0, down 29.46% from the prior year.
- Non-Current Assets declined to $203024.0 in Q1 2026 per VYCO's latest filing, from $266998.0 in the prior quarter.
- Over five years, Non-Current Assets peaked at $428581.0 in Q3 2023 and troughed at $203024.0 in Q1 2026.
- A 5-year average of $342679.6 and a median of $342415.0 in 2022 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2026: Non-Current Assets gained 23.13% in 2024, then sank 40.31% in 2026.
- A 5-year view of Non-Current Assets shows it stood at $342415.0 in 2022, then climbed by 19.21% to $408208.0 in 2023, then declined by 7.28% to $378503.0 in 2024, then declined by 29.46% to $266998.0 in 2025, then decreased by 23.96% to $203024.0 in 2026.
- Business Quant data shows VYCO's Non-Current Assets at $203024.0 in Q1 2026, $266998.0 in Q4 2025, and $278599.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Vycor Medical | - | - | 375,153.00 | 203,024.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 203,024.00 |
| Dec 31, 2025 | 266,998.00 |
| Sep 30, 2025 | 278,599.00 |
| Jun 30, 2025 | 324,591.00 |
| Mar 31, 2025 | 340,136.00 |
| Dec 31, 2024 | 378,503.00 |
| Sep 30, 2024 | 331,174.00 |
| Jun 30, 2024 | 353,478.00 |
| Mar 31, 2024 | 380,612.00 |
| Dec 31, 2023 | 408,208.00 |
| Sep 30, 2023 | 428,581.00 |
| Jun 30, 2023 | 287,070.00 |
| Mar 31, 2023 | 314,662.00 |
| Dec 31, 2022 | 342,415.00 |
| Sep 30, 2022 | 370,022.00 |
| Jun 30, 2022 | 397,386.00 |
| Mar 31, 2022 | 420,095.00 |
| Dec 31, 2021 | 447,953.00 |
| Sep 30, 2021 | 477,402.00 |
| Jun 30, 2021 | 500,569.00 |